CBSE Board Exams 2026 Live: How Was Class 12 Physics Paper? Detailed Analysis Here

CBSE Board Exams 2026 Live: The Class 12 Physics exam was conducted today alongside six Class 10 papers, Beauty and Wellness, ...

Should class rank return? Anne Arundel school board divided on proposal.

Should class rank return to Anne Arundel high schools? Some board members highlight college application benefits, while ...

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

Genomics and synthetic biology are reshaping healthcare, as rapid DNA sequencing advances power personalized medicine and ...

Innovation at Scale: Why Shandong Yupai Biotechnology is the Global Leading Pet Food Manufacturer to Watch in 2026

SHANDONG, SHANDONG, CHINA, January 28, 2026 /EINPresswire.com/ -- In the rapidly evolving world of pet care, where "pet ...

Johnson & Johnson: RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line ...

Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...
Santé log

O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated

Poster number: P0932 Title: The First-in-Class SIK3 Inhibitor O3R-5671 Demonstrates Optimal Pharmacokinetics and Potent and Sustained Pharmacodynamic Activity in Human Participants Presentation time: ...

Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds Profitability

Ardelyx will need to demonstrate better cost management over time for investors to build confidence here. Click here to find ...

U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and ...
AHA/ASA Journals

HEV-Targeted Antibody-Drug Conjugate Promotes Long-Term Cardiac Allograft Acceptance

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...